Clinical Trials Logo

Clinical Trial Summary

A Prospective Multicenter Randomized Interventional Study. Blood transfusion can be lifesaving in extreme circumstances, in the absence of life threatening hemorrhage, the indications for transfusion are somewhat controversial. The aim of the current study is to determine whether a"liberal" strategy of maintaining Hb concentrations above 9 g/dL would result in a different neurological outcome when compared to a "restrictive" approach to red-cell transfusion to avoid hemoglobin concentrations < 7 g/dL in critically ill anemic patients (i.e. Hb< 9 g/dL) with acute brain injury.


Clinical Trial Description

Background: Although blood transfusions can be lifesaving in severe hemorrhage, they could also result in several potential complications. As anemia has also been associated with poor outcome in critically ill patients,optimal transfusion trigger is a real challenge for clinicians. This is even more important in patients with acute brain injury who were not specifically evaluated in previous large randomized clinical trials dealing with the optimal transfusion threshold. Neurological patients may be particularly sensitive to anemic brain hypoxia because of the exhausted cerebro-vascular reserve, which adjust cerebral blood flow to tissue oxygen demand.

Methods/Design: The investigators describe herein the methodology of a prospective, multicenter, randomized, pragmatic trial comparing two different strategies to initiate red blood cells transfusions in patients with acute brain injury: a "liberal" strategy, which aims to maintain hemoglobin(Hb) concentrations above 9 g/dL and a "restrictive" approach to blood transfusion that maintains hemoglobin concentrations above 7 g/dL. Target population includes patients suffering from traumatic brain injury (TBI), subarachnoid hemorrhage (SAH) and intracranial hemorrhage (ICH). The primary outcome is neurological outcome, evaluated using extended Glasgow Outcome Scale (eGOS), at 180 days after the initial injury. Secondary outcomes include, amongst all, 28-day survival, intensive care unit (ICU) and hospital length of stay, the occurrence of extra-cerebral organ dysfunction/failure and the development of any infection or thromboembolic events (either venous or arterial). The estimated sample size to demonstrate a reduction in the primary outcome between groups from 50% to 45% is 4610 patients (2305 for each arm). The study will be initiated in 2015 within several European ICUs and conducted over 4 years.

Expected outcomes/Discussion: This trial will assess the impact of two different strategies to administer blood transfusions in a large cohort of critically ill patients with a primary brain injury. The results of this trial may help to better manage blood products and transfusion thresholds in this specific patients‟ population and will provide additional data in some sub-groups of patients at high-risk of brain ischemia, such as those with an intracranial hypertension or developing cerebral vasospasm. ;


Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Supportive Care


Related Conditions & MeSH terms


NCT number NCT02962349
Study type Interventional
Source European Society of Intensive Care Medicine
Contact Fabio S TACCONE, MD, PhD
Phone +3225555587
Email ftaccone@ulb.ac.be
Status Recruiting
Phase N/A
Start date September 2016
Completion date December 2020

See also
  Status Clinical Trial Phase
Terminated NCT03052712 - Validation and Standardization of a Battery Evaluation of the Socio-emotional Functions in Various Neurological Pathologies N/A
Recruiting NCT05503316 - The Roll of Balance Confidence in Gait Rehabilitation in Persons With a Lesion of the Central Nervous System N/A
Completed NCT04356963 - Adjunct VR Pain Management in Acute Brain Injury N/A
Completed NCT03418129 - Neuromodulatory Treatments for Pain Management in TBI N/A
Terminated NCT03698747 - Myelin Imaging in Concussed High School Football Players
Recruiting NCT05130658 - Study to Improve Ambulation in Individuals With TBI Using Virtual Reality -Based Treadmill Training N/A
Recruiting NCT04560946 - Personalized, Augmented Cognitive Training (PACT) for Service Members and Veterans With a History of TBI N/A
Completed NCT05160194 - Gaining Real-Life Skills Over the Web N/A
Recruiting NCT02059941 - Managing Severe Traumatic Brain Injury (TBI) Without Intracranial Pressure Monitoring (ICP) Monitoring Guidelines N/A
Recruiting NCT03940443 - Differences in Mortality and Morbidity in Patients Suffering a Time-critical Condition Between GEMS and HEMS
Recruiting NCT03937947 - Traumatic Brain Injury Associated Radiological DVT Incidence and Significance Study
Completed NCT04465019 - Exoskeleton Rehabilitation on TBI
Recruiting NCT04530955 - Transitioning to a Valve-Gated Intrathecal Drug Delivery System (IDDS) N/A
Recruiting NCT03899532 - Remote Ischemic Conditioning in Traumatic Brain Injury N/A
Suspended NCT04244058 - Changes in Glutamatergic Neurotransmission of Severe TBI Patients Early Phase 1
Completed NCT03307070 - Adapted Cognitive Behavioral Treatment for Depression in Patients With Moderate to Severe Traumatic Brain Injury N/A
Recruiting NCT04274777 - The Relationship Between Lipid Peroxidation Products From Traumatic Brain Injury and Secondary Coagulation Disorders
Withdrawn NCT05062148 - Fundamental and Applied Concussion Recovery Modality Research and Development: Applications for the Enhanced Recovery N/A
Withdrawn NCT04199130 - Cognitive Rehabilitation and Brain Activity of Attention-Control Impairment in TBI N/A
Withdrawn NCT03626727 - Evaluation of the Efficacy of Sodium Oxybate (Xyrem®) in Treatment of Post-traumatic Narcolepsy and Post-traumatic Hypersomnia Early Phase 1